Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A De Man

Showing results (331-340 of 543) with videos related to

Pageof 55
Sort By:
Clinics and Research in Hepatology and Gastroenterology|June 6, 2022
Hepatitis E infection with a benign course during vedolizumab treatment for Crohn's disease: A case reportR L Goetgebuer, G M C Masclee, A A van der Eijk, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 20, 2010
[Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study]Carlijn D M Witjes, Robert A de Man, Ferry A L M Eskens, et al.
Scientific Reports|August 17, 2017
Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized miceMartijn D B van de Garde, Suzan D Pas, Gertine W van Oord, et al.
Cancers|February 15, 2022
External Validation of the RETREAT Score for Prediction of Hepatocellular Carcinoma Recurrence after Liver TransplantationMaria C van Hooff, Milan J Sonneveld, Jan N Ijzermans, et al.
Journal of Surgical Oncology|August 13, 2015
Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinomaStef Levolger, Mark G van Vledder, Rahat Muslem, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 22, 2015
Hepatitis E virus genotype 3 infection in a tertiary referral center in the Netherlands: Clinical relevance and impact on patient morbidityCharlotte M Nijskens, Suzan D Pas, Jan Cornelissen, et al.
Journal of Viral Hepatitis|May 20, 2003
The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infectionT J Tang, J Kwekkeboom, J D Laman, et al.
Journal of Viral Hepatitis|January 27, 2006
Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alphaA A van der Eijk, H G M Niesters, B E Hansen, et al.
Gastroenterology|August 4, 2009
Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trialLoes van Keimpema, Frederik Nevens, Ragna Vanslembrouck, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 16, 2014
Hepatitis E prevalence among HIV infected patients with elevated liver enzymes in the NetherlandsR J Hassing, A A van der Eijk, V Baptista Lopes, et al.
Pageof 55

Showing results (331-340 of 543) with videos related to

Sort By:
Pageof 55
Clinics and Research in Hepatology and Gastroenterology|June 6, 2022
Hepatitis E infection with a benign course during vedolizumab treatment for Crohn's disease: A case reportR L Goetgebuer, G M C Masclee, A A van der Eijk, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 20, 2010
[Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study]Carlijn D M Witjes, Robert A de Man, Ferry A L M Eskens, et al.
Scientific Reports|August 17, 2017
Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized miceMartijn D B van de Garde, Suzan D Pas, Gertine W van Oord, et al.
Cancers|February 15, 2022
External Validation of the RETREAT Score for Prediction of Hepatocellular Carcinoma Recurrence after Liver TransplantationMaria C van Hooff, Milan J Sonneveld, Jan N Ijzermans, et al.
Journal of Surgical Oncology|August 13, 2015
Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinomaStef Levolger, Mark G van Vledder, Rahat Muslem, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 22, 2015
Hepatitis E virus genotype 3 infection in a tertiary referral center in the Netherlands: Clinical relevance and impact on patient morbidityCharlotte M Nijskens, Suzan D Pas, Jan Cornelissen, et al.
Journal of Viral Hepatitis|May 20, 2003
The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infectionT J Tang, J Kwekkeboom, J D Laman, et al.
Journal of Viral Hepatitis|January 27, 2006
Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alphaA A van der Eijk, H G M Niesters, B E Hansen, et al.
Gastroenterology|August 4, 2009
Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trialLoes van Keimpema, Frederik Nevens, Ragna Vanslembrouck, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 16, 2014
Hepatitis E prevalence among HIV infected patients with elevated liver enzymes in the NetherlandsR J Hassing, A A van der Eijk, V Baptista Lopes, et al.
Pageof 55